Sagent Pharm Inc (SGNT) 21.69 $SGNT Sapiens Names Andre

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 9:19 AM

Sagent Pharm Inc (SGNT) 21.69 $SGNT

Sapiens Names Andre M. Boisvert Chairman of Sapiens DECISION Board of Directors
PR Newswire - Thu Jul 28, 8:12AM CDT
Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the financial services sector, announced today that veteran software industry executive, private investor and technology consultant Andre M. Boisvert was nominated to serve as the chairman of the board of directors of Sapiens DECISION.
SPNS: 12.78 (-0.06), ISDR: 7.20 (+0.05), SGNT: 21.69 (+0.02)

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Sagent Pharmaceuticals, Inc. to Nichi-Iko Pharmaceutical Co., Ltd. for $21.75 Per Share is Fair to Shareholders
BusinessWire - Mon Jul 18, 11:55AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
SGNT: 21.69 (+0.02)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Sagent Pharmaceuticals, Inc. - SGNT
ACCESSWIRE - Fri Jul 15, 5:05PM CDT
BALA CYNWYD, PA / ACCESSWIRE / July 15, 2016 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Sagent Pharmaceuticals, Inc. ("Sagent" or "the Company"

(NASDAQ: SGNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Nichi-Iko Pharmaceutical Co., Ltd. ("Nichi-Iko"

.
SGNT: 21.69 (+0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning the Sale of Sagent Pharmaceuticals, Inc. to Nichi-Iko Pharmaceutical Co., Ltd. for $21.75 Per Share is Fair to Shareholders -- SGNT
PR Newswire - Wed Jul 13, 4:15PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
SGNT: 21.69 (+0.02)

Company News for July 12, 2016
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 9:10AM CDT
Companies In The News are: KMI,SO,SGNT,BA,OZRK
KMI: 20.25 (-0.08), SGNT: 21.69 (+0.02), BA: 133.66 (unch), SO: 53.50 (+0.24), OZRK: 35.99 (-0.23)

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Sagent Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
BusinessWire - Mon Jul 11, 7:10PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) ("Sagent" or the "Company"

relating to the proposed buyout of Sagent by Nichi-Iko Pharmaceutical Co., Ltd. The firm's investigation seeks to determine, among other things, whether the Company's Board of Directors failed to satisfy their duties to shareholders, including whether the Board adequately pursued alternatives to the acquisition and whether the Board obtained the best price possible for the Company's shares of common stock.
SGNT: 21.69 (+0.02)

Alliance Data and Kinder Morgan rise; Eversource falls
AP - Mon Jul 11, 3:23PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Monday:
NFLX: 91.00 (-0.25), KMI: 20.25 (-0.08), SGNT: 21.69 (+0.02), BA: 133.66 (unch), SO: 53.50 (+0.24), ADS: 231.62 (-2.22)

SAGENT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Mon Jul 11, 9:20AM CDT
Rigrodsky & Long, P.A.:
SGNT: 21.69 (+0.02)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Whether the Sale of Sagent Pharmaceuticals, Inc. to Nichi-Iko Pharmaceutical Co., Ltd. for $21.75 Per Share is Fair to Shareholders - SGNT
ACCESSWIRE - Mon Jul 11, 9:10AM CDT
NEW YORK, NY / ACCESSWIRE / July 11, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
SGNT: 21.69 (+0.02)

SAGENT(SGNT) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Sagent Pharmaceuticals, Inc.; Are Shareholders Getting a Fair Price?
PR Newswire - Mon Jul 11, 6:56AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) breached their fiduciary duties in connection with the proposed sale of the Company to Nichi-Iko Pharmaceutical Co., Ltd.
SGNT: 21.69 (+0.02)

Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction
BusinessWire - Mon Jul 11, 1:30AM CDT
--Marks a significant step in Nichi-Iko's international growth strategy through establishment of U.S. platform
SGNT: 21.69 (+0.02)

Athenex Announces the Addition of James Hussey to Lead its Commercial Business Activities
PR Newswire - Fri Jul 08, 8:00AM CDT
Athenex, Inc. announced today that James Hussey has joined the Company as Executive Vice President of Athenex Pharmaceutical Division. In this capacity, Mr. Hussey will be responsible for the execution of the commercial aspects of this business unit including strategy, new products, manufacturing, distribution, sales and marketing.
SGNT: 21.69 (+0.02)

Sagent Pharmaceuticals Acquires Product Portfolio From Teva Pharmaceutical Industries Ltd.
GlobeNewswire - Thu Jun 16, 7:00AM CDT
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leading provider of affordable pharmaceuticals to the hospital market, today announced that it has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd. (Teva) and Actavis LLC to acquire a portfolio of five Abbreviated New Drug Applications (ANDAs) in the U.S. for $40 million. The acquired portfolio includes products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business.
AGN: 253.90 (+0.95), SGNT: 21.69 (+0.02), TEVA: 53.67 (+0.17)

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10g Due to Presence of Dark Particulate Matter
GlobeNewswire - Mon Jun 13, 4:52PM CDT
Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Oxacillin for Injection, USP, 10g (NDC 25021-163-69) Lot OXT515 (Exp. Date July 2017) manufactured by Astral SteriTech Private Limited and distributed by Sagent. Sagent has initiated this voluntary recall of Oxacillin for Injection, USP, 10g to the user level due to the receipt of two product complaints for small, dark particulate matter found in solution after reconstitution. The presence of particulate matter during administration has the potential to cause adverse health consequences in general patient populations.
SGNT: 21.69 (+0.02)

Sagent reports 1Q loss
Automated Insights - Tue May 03, 6:52AM CDT
SCHAUMBURG, Ill. (AP) _ Sagent Pharmaceuticals Inc. (SGNT) on Tuesday reported a loss of $5 million in its first quarter.
SGNT: 21.69 (+0.02)

Sagent Pharmaceuticals Reports First Quarter 2016 Financial Results
GlobeNewswire - Tue May 03, 6:30AM CDT
Company Affirms 2016 Full Year Guidance
SGNT: 21.69 (+0.02)

Athenex Announces Jeffrey Yordon to Lead Newly Formed Specialty Products Division
PR Newswire - Tue Apr 26, 7:00AM CDT
Athenex, Inc. announced today that Jeffrey Yordon has joined the Company as President of the newly formed subsidiary, Athenex Specialty Products. In this capacity, Mr. Yordon will be responsible for all aspects of the business unit including strategy, new products, manufacturing, distribution, sales and marketing.
SGNT: 21.69 (+0.02)

Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2016 Financial Results
GlobeNewswire - Mon Apr 25, 8:07AM CDT
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leading provider of affordable pharmaceuticals to the hospital market, today announced that it will release financial results for the 2016 first quarter pre-market on Tuesday, May 3, 2016 and will host a teleconference and webcast at 9 a.m. ET to review the results.
SGNT: 21.69 (+0.02)

Stock Picking Strategy to Win Every Earnings Season
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 5:27PM CDT
We are running a great screen which will help you get into winning stocks ahead of every earnings season.
CPN: 13.74 (-0.49), INGN: 53.74 (+1.00), SGNT: 21.69 (+0.02), MTN: 143.07 (-0.30), PFSW: 9.91 (-0.18)

Sagent Pharmaceuticals Names Sean Brynjelsen Executive Vice President, Business Development
GlobeNewswire - Wed Mar 23, 3:05PM CDT
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leading provider of affordable pharmaceuticals to the hospital market, announced the hiring of Sean Brynjelsen as Executive Vice President, Business Development. In this newly created role, Mr. Brynjelsen will develop and execute a strategy to drive long-term growth through the acceleration of product licensing, acquisition of products and portfolios as well as the execution of other M&A activity. Mr. Brynjelsen will report directly to Allan Oberman, Sagent's Chief Executive Officer.
SGNT: 21.69 (+0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Rutter Mills Secures $13M in Virginia Injury Cases

The Stakes in Virginia When you drop nine successful injury cases on the scales and they tip over $13 million, that's a story worth dissecting. The two top dogs at Rutter Mills certainly know how to make a splash in the legal puddle, don't they? We're talking about attorneys Adam H. Lotkin and Georgina D. Montgomery here, the legal eagles behind these jaw-dropping...

Morphe’s Auction Hits High Notes with Fine Jewelry

Luxurious Gems Steal the Spotlight When the gavel dropped at Morphy's Fine Jewelry & Watches Auction, it set the stage for a spectacular showcase of opulent treasures. The event, highlighting 632 lots and tallying over $1.8 million in sales, left bidders buzzing in anticipation of their next chance to snag a slice of elegance. Bvlgari's Serpentine Charm In the spotlight...

Ajman Tourism Department Hits Internal Audit Milestone

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Newfold Digital Revamps Leadership for Growth Surge

Steering into New Horizons with Fresh Leadership October 2026 marks a fresh chapter for Newfold Digital, as they shuffle the deck chairs a bit and ramp up for some ambitious growth endeavors. This web and commerce tech company decided it's time to bring a few heavy hitters on board. Starting this month, watch out for Sachin Puri taking the reins as Chief Executive...

Moore, Schulman & Moore Attorneys Earn Top Honors Again

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

Teamsters Secure Landmark Deal for SF Parking Workers

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

AI Visibility: A Game Changer for SEO in 2027?

AI Changes the SEO Game Rank Math, the brains behind a trusty WordPress SEO plugin, has thrown a bold prediction at us: AI visibility is set to become a standard SEO metric next year. Gurugram, India, saw this gem of an announcement on October 9, 2026. So, what's ticking here? Consumers, more than ever, are resting on AI-generated answers to make decisions. It's like...

STRATA Showcases Excimer Laser Success in Dermatology

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

Ingram Mercantile's Aviation Push: SCORE or Sink?

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...